Archive for the ‘Insight into’ Category

MMR Vaccines and possble causes of Autism.

Tuesday, September 9th, 2008

You know, I had heard it was a disgruntled ex employee of a Pharmaceutical company that started this whole MMR connection, if that is true this person should be tarred an feathered and tied to a whipping post in the village square for wasting so many valuable years of research down a wrong street, years that could have been used to find a cause and cure. Instead, we have wasted big time dollars and time accusing and defending.. What a shame, Now this article appeared int he NY Times claiming that the researchers had a conflict of interest who published the findings.. all this for what, a Gov’t grant or a mention in some Journal?

“Meanwhile, the original paper’s publisher — The Lancet — complained in 2004 that the lead author had concealed a conflict of interest. Ten of his co-authors retracted the paper’s implication that the vaccine might be linked to autism. Three of the authors are now defending themselves before a fitness-to-practice panel in London on charges related to their autism research.

Sadly, even after all of this, many parents of autistic children still blame the vaccine. The big losers in this debate are the children who are not being vaccinated because of parental fears and are at risk of contracting serious — sometimes fatal — diseases.”

How about we shift towards researching things introduced into the environment that mirror the rise of Autism, Such as; Cell Phones, PC’s, Plastic Everything, Teflon, Hormone use in the food supply, even down to Hydro-Ponic Marijuana. Doesnt anyone else wonder about these things and their possible place in the cause of the Autism Epidemic? Anyone there?

Ten years ago, a clinical research paper triggered widespread and persistent fears that a combined vaccine that prevents measles, mumps and rubella — the so-called MMR vaccine — causes autism in young children. That theory has been soundly refuted by a variety of other research over the years, and now a new study that tried to replicate the original study has provided further evidence that it was a false alarm. Read More from this New York Times article

Cord Blood, Stem Cells and Autism

Monday, August 11th, 2008

My wife and I are blessed with 2 children and are expecting our third in October. We have been contemplating storing the umbilical cord for future use for someone in the family, should one of us become sick or if a break through occurs and we can help those with Autism Spectrum Disorder with this invaluable resource. We have decided it is worth the expense – $4,000 for a 20 year storage. Has anyone out there done this and actually used the blood to harvest stem cells? if so, please write to us.

This story hit the web recently, it helps to validate our decision for sure.

Scientists Grow Stem Cells For Parkinson’s, Down Syndrome, Other Disorders

By Stephanie Nano, Associated Press

AP – Harvard scientists say they have created stems cells for 10 genetic disorders, which will allow researchers to watch the diseases develop in a lab dish.
This early step, using a new technique, could help speed up efforts to find treatments for some of the most confounding ailments, the scientists said.
The new work was reported online Thursday in the journal Cell, and the researchers said they plan to make the cell lines readily available to other scientists.
Dr. George Daley and his colleagues at the Harvard Stem Cell Institute used ordinary skin cells and bone marrow from people with a variety of diseases, including Parkinson’s, Huntington’s and Down syndrome to produce the stem cells.
The new cells will allow researchers to “watch the disease progress in a dish, that is, to watch what goes right or wrong,” Doug Melton, co-director of the institute, said during a teleconference.
“I think we’ll see in years ahead that this opens the door to a new way to treating degenerative diseases,” he said.
The new technique reprograms cells, giving them the chameleon-like qualities of embryonic stem cells, which can morph into all kinds of tissue, such as heart, nerve and brain. As with embryonic stem cells, the hope is to speed medical research.
Research teams in Wisconsin and Japan were the first to report last November that they had reprogrammed skin cells, and that the cells had behaved like stem cells in a series of lab tests. Just last week, another Harvard team of scientists said they reprogrammed skin cells from two elderly patients with ALS, or Lou Gehrig’s disease, and grew them into nerve cells.
Melton said the new disease-specific cell lines “represent a collection of degenerative diseases for which there are no good treatments and, more importantly, no good animal models for the most part in studying them.”
A new laboratory has been created to serve as a repository for the cells, and to distribute them to other scientists researching the diseases, Melton said.
“The hope is that this will accelerate research and it will create a climate of openness,” said Daley.
He expects stem cell lines to be developed for many more diseases, noting, “this is just the first wave of diseases.” Other diseases for which they created stem cells are Type 1, or juvenile, diabetes; two types of muscular dystrophy, Gaucher disease and a rare genetic disorder known as the “bubble boy disease.”
Daley stressed that the reprogrammed cells won’t eliminate the need or value of studying embryonic stem cells.
“At least for the foreseeable future, and I would argue forever, they are going to be extremely valuable tools,” he said.
The reprogramming work was funded by the National Institutes of Health and private contributions to the Harvard Stem Cell Institute.

Video Modeling … seems like a great idea!

Saturday, July 5th, 2008

Came across this video series, http://www.modelmekids.com/autism-videos.html

Anyone ever use it? What were your results? Seems like a great idea and one I have often thought about given my sons love of the video tape, or dvd.

Thanks for sharing… is there anybody out there??

The Time for School video presents social skills in the context of school. It features elementary school-aged children demonstrating appropriate social skills in the classroom, library, on the playground, and in the hallway. Each scene lasts between 30 seconds and 3 minutes, depending on the chapter. At the end of each chapter is a storyboard summarizing the rules taught.

The video is hosted by a young boy, who narrates each scene.

With narration: In the first half of the video, the visual is combined with narration and graphics that help explain the particular rule.

Without narration: In the second half of the video, the same video is repeated without narration and graphics. This allows a parent, Autism teacher, or therapist to customize the lesson the individual child and/or to test what was learned in the first viewing of the video.

Each social skill is demonstrated in more than one situation and across environments. This is useful to children with Autism and Asperger’s Syndrome because it helps with generalization of the skill taught.

Graphics and music are used to make the video appealing to children with Autism, Asperger’s Syndrome, and Nonverbal Learning Disorders. A high production value helps keep the child’s interest so that he or she will want to watch many times.

Check it out here

The Myelin Project – Lorenzos Oil

Thursday, June 12th, 2008

Research: “The Myelin Project”:

The exciting work of researchers funded by The Myelin Project, whose goal is to remyelinate the human central nervous system, may someday have benefits for autistic children. Only time will tell if a specific area of damaged neurons can be found and potentially repaired with stem cells.

The first human trial, conducted by Dr. Timothy Vollmer at Yale University School of Medicine, will attempt to transplant myelin-forming Schwann cells into the brains of five patients with multiple sclerosis. The cells will be obtained from the sural nerves of the patients themselves. Although Schwann cells normally produce myelin in the peripheral nervous system, several recent experiments conducted on rodents and cats have shown these cells have the ability to remyelinate in the CNS as well.

While multiple sclerosis is a long way from autism, there is discussion of anti-myelin antibodies in autism, and there is talk of inflammatory processes involving myelin. Whether this technology can help autism if it works for multiple sclerosis is anybody’s guess, but it’s exciting to wonder about.

The Myelin Project funds a Cell Culture Unit at the University of Wisconsin-Madison, where Dr. Su-chun Zhang continues to generate cultures with ever-higher percentages of human oligodendrocyte precursors (OPs). Oligodendrocytes are the cells that normally myelinate the CNS. If obtainable in sufficient quantity, they would provide an alternative to Schwann cells for transplantation. The Unit has developed a method to track transplanted OPs by MRI, labeling the cells with iron particles. In another recent experiment, Dr. Baron-Van Evercooren and colleagues were able to remyelinate as many as 55% of the nerves in monkey spinal cord lesions by transplanting the monkeys’ own Schwann cells. These initial positive results, however, have not been confirmed in subsequent attempts. She suspects that the viral labels she used to distinguish the transplanted cells caused them to die. She is trying again without viral labeling. If successful, this experiment would prove that CNS remyelination is feasible in higher animals.

Several researchers funded by The Myelin Project have injected myelin-forming cells into the ventricles of the brain of experimental animals and have shown that these cells were transported by the cerebrospinal fluid to all regions of the brain. This makes it more likely that injected cells will travel to where the myelin needs to be repopulated.

The Myelin Project has funded Dr. Oliver Br�stle of the University of Bonn, Germany, and Dr. Evan Snyder of Harvard University to work with neural stem cells (NSC). These are self-renewing, multipotent cells, capable of differentiating into the major types of neural cells, including oligodendrocytes. One of their most potentially beneficial properties is their tendency to respond to signals in the CNS environment. In CNS diseases, these signals guide the cells to damaged areas. Second, they prompt them to differentiate into the specific cell type needed for the repair — neurons in nerve diseases like Parkinson’s and oligodendrocytes in myelin disorders like the leukodystrophies and multiple sclerosis.

NSCs are typically of fetal origin, but have also been found in the adult brain. NSCs can be multiplied in culture indefinitely as an “immortal” cell line. They could eventually provide an inexhaustible source of myelin-forming cells, eliminating the need for obtaining them from fresh tissue. Several research centers are now testing human NSCs to verify their safety and in particular to rule out any risk of their becoming cancerous. If this testing concludes favorably, then prospective myelin repair strategies could take a two-fold approach. NSCs would be injected into the ventricular system where the cerebrospinal fluid would circulate them to all parts of the CNS. Local signals would then come into play, guiding the cells to the specific demyelinated areas.

The Myelin Project has also funded Dr. Robin Franklin of the University of Cambridge to study olfactory ensheathing cells, a third type of myelin-producing cell. He has perfected a technique for demyelinating the area of rat brain connecting the cerebellum with the brain stem. He subsequently remyelinated the area by transplanting rat Schwann cells, which adds to the body of evidence in favor of Schwann cell transplantation as a way of repairing CNS myelin lesions.

The Myelin Project has also funded Dr. Inderjit Singh of the Medical University of South Carolina to study the use of Lovastatin in the treatment of myelin disorders. The drug corrects the biochemical defect of adrenoleukodystrophy, lowering the levels of very long chain fatty acids in plasma. Preliminary studies with an animal model of MS have confirmed Lovastatin’s ability to block the induction of cytokines, substances responsible for the inflammation of the CNS. We know that the levels of very long chain fatty acids and of some cytokines are elevated in autism. I am wonderijng already if Lovastatin might be worth trying for children with documented elevated very long chain fatty acids and elevated cytokines.

These studies present exciting possibilities for the future for treating neurodegenerative diseases. They may eventually have relevence for such diverse conditions as autism, cerebral palsy, and CNS vaccine damage syndromes. Time will tell.

find more at http://www.healing-arts.org/children/cell.htm

Celebrity, Scmelebrity

Thursday, June 12th, 2008

Where as I appreciate any and most attention Autism receives, I feel a bit sickened by the fact that celebrity’;s seem to be leanding their names solely for the purpose of publicity.

Jenny is cool, but her book talks about she is able to afford the therapy’s that most of us only dream of or mortgage our homes for.  the therapy’s she mentions in the book are not hers, they are those of Berdard and Tomatis. Deidre Imus was a big factor in passing the Combating Autism Act, which is a lame act of empty promises. Where is she now? Robert Kennedy, now I was shocked to see how much attention he gets for helping Autism get reserach dollars, I thought he was an enviormentalist? And what is President Bill; Clintoln doing rasing money for children in far off lands, most of which wil never even see the dollasr raised when 1 in 150 children in the US are diagnosed with Autism, shame on you Bill! I don’t know, maybe I am wrong here and maybe, just maybe getting celebrity endorsement is better than none, but what have we gained since Autism is such a celebrity cause? A few best sellers or rehashed gobblee goop?

This is not a part time thing here, this is a life long condition and for most finanacial burden. What do we have to do, go on TV and get sponsors for individual families here in the states? We need insurance reforms like we see taking place in a few states like New Jersey, we need the medical community to rally here. Autism is horrible and the numbers climb ever day, why is it not being treated as an epidemic, but rather as a celebrity attention grabber!!?? What are your thoughts. Please share them and lets take the bull by the horns ourselves and Unlock Autism.

Take Care of Yourself

Monday, June 9th, 2008

It’s kind of like being on a plane, the flight attendant tells everyone in the event of an emergency … if due to a sudden drop in cabin pressure and the air mask drops, to put your mask on first so that you can assist your child and others. It carries through to taking care of someone like an Autistic Child.

Lets face it, a parent of a special needs child needs to be so much more than Special, we need to be Super, at all times and at all things. Friends are a gasp to hear of what a special needs family has to endure in order to get their kid in their home school district. Even the most basic of things in life that are taken for granted can be huge challenges. We just want our children to have the opportunity to cash in on a long and productive life.

So lets keep in mind, if we as Parents don’t take care of ourselves, we won’t be able to adequately take care of the people who are most important in our lives, for very long.

So make it a point to enjoy your life- including your physical and mental health. Create and make time to rejuvenate and replenish your mind, body and spirit. Make and go to that long overdue doctors appointment for yourself , take an hour per day to read, a day per month to Spa, a night out with friends, a weekend escape- whatever it is, do it and be strong for your kids.

Being on top of your game here means more than love, caring and understanding. Its staying healthy and wise and up with things in the move.

So make that commitment to yourself and the quality of your goodness and care will shine.

Here is a site you can look for travel ideas. ExplorerPod.com.

Health, Spiritual and Wellness try MorningCoach.com

A link to Pass Time Google Maps. Check out your house for a new perspective.

Some great tunes and channels. DeadShowPodcast.com

Seriously, do something for yourself today, so you can continue to take care of your kids tomorrow.

Share Your Wisdom

Tuesday, May 27th, 2008

We could use a hand in finding material to share with others like you. If you have an experiences or know of other great resources for information, Please leave some comments or write to us at info@unlockautism.com This site is for us all. We are trying to direct you to pertinent information about Autism. Success stories and information about therapy’s and diets which helped or those which didn’t. Keep in mind, not all therapy’s will work for all. Autistic people are individuals in the truest sense of the word, with loving and caring families trying to unlock autism and let that person out.

If we can gather enough stats and information, perhaps we can help others. For us personally, Its been a whole lot of Love, Therapy’s and at times Snake Oil. Whats worked for us has been, ABA, Signing Time, Auditory Integration and Omega’s plus the usual OT, PT and Speech. But also encouraging more social engagement.

All I know is that we as parents know what works and what doesn’t, lets help those who are just discovering Autism. Let us help each other from being fooled by the latest and greatest therapy’s promising miracle and instant cures.
If you are interested in getting involved with UnlockAutism.com, let us know and share your wisdom.

Autism and Maternal Antibodies

Tuesday, May 20th, 2008

Original Article Found on TranslatingAutism.com You can find a more complete description and review of this paper based on the press coverage here. Thus, I’ll limit this to a micro summary and a few related thoughts. The researchers wanted to experimentally test the hypothesis that exposure to maternal neuronal antibodies (IgG) during the PREnatal period could be one of the causes of at least some variants of Autism. To test this hypothesis the researchers exposed 4 prenatal rhesus monkeys with IgG taken from human mothers who had multiple children with ASD. They also exposed 5 prenatal monkeys with IgG taken from human mothers who did not have any children with Autism. Once the monkeys were born, these two groups were also compared to monkeys that had not been exposed to any antibodies. The researchers found that the monkeys that had been exposed to the antibodies of human mothers of children with autism engaged in much higher levels of unique whole-body stereotypic behaviors and less social contact with familiar peers, than did the monkeys exposed to IgG of mothers of typically developing kids or monkeys not exposed to any antibodies. Furthermore, these stereotypic behaviors increased when the monkeys were exposed to novel environments or peers. As I understand how controversial this paper will be for some people, I want to say that the authors are very clear and explicit in stating that this is NOT an animal model of autism. That is, they did not intent to say that they were able to “cause” autism in these monkeys via exposure to IgG. Instead, their data presents some evidence that exposure to IgG before birth leads to unique patterns of stereotypic behaviors, similar to those observed in some children with ASD. This is a very small preliminary study, but the results are fascinating in that it will guide future research to explore exposure to IgG as a potential cause (one of many) of ASD.

Seems plausible since the IgG antibodiy can get through the placenta to protect the baby..but much more work needs to be done first. For more on IgG http://en.wikipedia.org/wiki/IgG

Vaccinated Monekys Show Autistic Signs

Tuesday, May 20th, 2008

From Age of Autism – What will happen to the Monkees ?

The first research project to examine effects of the total vaccine load received by children in the 1990s has found autism-like signs and symptoms in infant monkeys vaccinated the same way. The study’s principal investigator, Laura Hewitson from the University of Pittsburgh, reports developmental delays, behavior problems and brain changes in macaque monkeys that mimic “certain neurological abnormalities of autism.”

The findings are being reported Friday and Saturday at a major international autism conference in London.

Although couched in scientific language, Hewitson’s findings are explosive. They suggest, for the first time, that our closest animal cousins develop characteristics of autism when subjected to the same immunizations – such as the MMR shot — and vaccine formulations – such as the mercury preservative thimerosal — that American children received when autism diagnoses exploded in the 1990s.

The first publicly reported results of this research project come in both oral and poster presentations on Friday and Saturday at the International Meeting For Autism Research in London. Poster presentations must go through a form of peer review before they are presented at the conference; the papers have not yet appeared in a scientific journal.

In addition to Hewitson’s oral presentation today, on Saturday in one of two related poster presentations, the researchers also are reporting in their abstract that “vaccinated animals exhibited progressively severe chronic active inflammation [in gastrointestinal tissue] whereas unexposed animals did not. We have found many significant differences in the GI tissue gene expression profiles between vaccinated and unvaccinated animals.” Numerous scientific studies, as well as many parents, report severe GI ailments in children with regressive autism.

The results are sure to be controversial, in part because they lend credence to studies first published in 1998 by British pediatric gastroenterologist Andrew Wakefield, one of Hewitson’s co-authors on these findings. He described an unusual inflammatory bowel condition in children who had regressed into autism after they received the measles-mumps-rubella (MMR) vaccination. Wakefield is currently fighting charges of medical misconduct in Britain over allegations of conflict-of-interest and improper procedures related to that paper. He denies the charges.

In the program for the conference, the 7th Annual International Meeting for Autism Research (IMFAR), there are three separate presentations listed that report results from the overall research program. The first, an oral presentation entitled “Pediatric Vaccines Influence Primate Behavior, and Amygdala Growth and Opioid Ligand Binding” (the “amygdala abstract”) was led by Dr. Hewitson and lists 12 co-authors, including five of her colleagues from the University of Pittsburgh and Dr. Wakefield. Other authors are chemists, pathologists and psychologists from the universities of Kentucky, California-Irvine, and Washington.

Hewitson’s introductory presentation will be followed by two poster presentations on Saturday; one of the two, “Pediatric Vaccines Influence Primate Behavior, and Brain Stem Volume and Opioid Ligand Binding”, was led by Wakefield and includes six additional co-authors.

It focuses on the developmental effect of vaccine exposures on brain growth during infancy. The second, “Microarray Analysis of GI Tissue in a Macaque Model of the Effects of Infant Vaccination,” was led by Steven Walker of Wake Forest University and performed gene array analysis on the intestinal tissues of the vaccinated and unvaccinated monkeys.

The studies address – albeit in animals, not children — one of the major criticisms by parents and scientists concerned about a possible link between the greatly stepped-up immunization schedule in the 1990s, including higher exposure to the mercury preservative, and autism. While the Food and Drug Administration approves individual vaccines as safe and effective, and an advisory committee to the Centers for Disease Control and Prevention recommends the childhood immunization schedule adopted by the states, the overall health outcomes from the total vaccine load, versus no vaccinations at all, have never been compared, the authors said.

A bill requiring the government to conduct a study of autism rates in unvaccinated American children is pending in the U.S. House of Representatives, co-sponsored by Reps. Carolyn Maloney (D-N.Y.) and Tom Osborne (R.-Neb.). Just this week, former National Institutes of Health Director Bernadine Healy called for more research into a possible vaccine link to autism and said the question had not been settled, despite repeated assertions to that effect by the CDC, the Institute of Medicine and the American Academy of Pediatrics.

In the abstract for today’s oral presentation, the authors noted that macaques, the type of monkey used in the study, “are commonly used in pre-clinical vaccine safety testing, but the combined childhood vaccine regimen, rather than individual vaccines, has not been studied. Childhood vaccines are a possible causal factor in autism, and abnormal behaviors and anomalous amygdala growth are potentially inter-related features of this condition.”

The study found evidence of both behavioral and biological changes after the 13 macaque monkey infants were administered proportional doses, adjusted for age, of the vaccines recommended between 1994 and 1999. Three monkeys were not given any vaccines.

“Primate development, cognition and social behavior were assessed for both vaccinated and unvaccinated infants using standardized tests developed at the Washington National Primate Research Center.” MRI and PET scans looked for brain changes after administration of the MMR.

“Compared with unexposed animals, significant neurodevelopmental deficits were evident for exposed animals in survival reflexes, tests of color discrimination and reversal, and learning sets,” the authors reported. “Differences in behaviors were observed between exposed and unexposed animals and within the exposed group before and after MMR vaccination. Compared with unexposed animals, exposed animals showed attenuation of amygdala growth and differences in the amygdala binding of [11C]diprenorphine. Interaction models identified significant associations between specific aberrant social and non-social behaviors, isotope binding, and vaccine exposure.”

One of the Saturday abstracts makes the further point that the research “revealed significant differences between exposed and unexposed animals” in the kinds of developmental behaviors a mother might be able to observe, “with delayed acquisition of root, suck, clasp hand, and clasp foot reflexes.” They conclude by noting that “This animal model examines the neurological consequences of the childhood vaccine regimen, Functional and … brainstem anomalies were evident in vaccinated animals that may be relevant to some aspects of autism. The findings raise important safety issues while providing a potential animal model for examining aspects of causation and disease pathogenesis in acquired neurodevelopmental disorders.”

Dan Olmsted is Editor of Age of Autism.

Researchers model Autism in Mice.

Wednesday, April 16th, 2008

Researchers from the Massachusetts Institute of Technology (MIT) have recently generated a mice model for autistic savants – a phenomenon in which an autistic person has an outstanding skill alongside his poor ability in social interactions. By using genetically engineered mice in which a specific protein in the brain was inactive, the researchers discovered an enhanced learning ability of the mice, but also an impaired long term memory, which resembles autism characteristics. The scientists hope that in the future, this work will lead to the development of treatment for autism and for other brain development disorders.
Read More